MERCER GLOBAL ADVISORS INC /ADV
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 853758
DENVER, CO
Position in REGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$15,493,749
+$3,810,725 QoQ
Shares Held
20,053
+32.5% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 23.662294918466063.ToString("F0")%
Shared 0.ToString("F0")%
None 76.33770508153394.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MERCER GLOBAL ADVISORS INC /ADV holds $216,661,656 across 109 Biotechnology names. REGN ranks #3 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
831,428 | $69,981,294 | |
| 2 | ORKA |
Oruka Therapeutics, Inc.
|
802,470 | $39,361,153 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
20,053 | $15,493,749 | |
| 4 | CAPR |
Capricor Therapeutics, Inc.
|
402,999 | $12,251,169 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
22,762 | $10,164,143 | |
| 6 | INCY |
Incyte Corp
|
93,266 | $8,778,195 | |
| 7 | ORMP |
Oramed Pharmaceuticals Inc.
|
1,910,540 | $6,495,836 | |
| 8 | EXEL |
Exelixis, Inc.
|
136,747 | $5,865,078 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,493,749 | 20,053 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,683,024 | 15,136 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $6,938,411 | 12,340 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,997,750 | 5,710 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,346,558 | 8,430 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $16,657,124 | 23,384 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $27,093,608 | 25,773 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $25,559,998 | 24,319 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $22,326,880 | 23,197 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $19,207,324 | 21,869 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $17,282,160 | 21,000 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $13,858,480 | 19,287 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $15,122,014 | 18,404 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $13,631,110 | 18,893 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $12,175,777 | 17,675 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $9,573,350 | 16,195 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $9,351,145 | 13,389 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $5,030,688 | 7,966 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $2,240,376 | 3,702 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,019,122 | 3,615 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,868,174 | 6,062 | Shares | Sole | 2021-08-10 | |
| 2020-12-31 | $2,102,494 | 4,352 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,435,275 | 2,564 | Shares | Sole | 2020-12-10 | |
| 2020-06-30 | $502,661 | 806 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $390,632 | 800 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||